KR20090094287A - 용출성이 개선된 의약 조성물 - Google Patents
용출성이 개선된 의약 조성물Info
- Publication number
- KR20090094287A KR20090094287A KR1020097012660A KR20097012660A KR20090094287A KR 20090094287 A KR20090094287 A KR 20090094287A KR 1020097012660 A KR1020097012660 A KR 1020097012660A KR 20097012660 A KR20097012660 A KR 20097012660A KR 20090094287 A KR20090094287 A KR 20090094287A
- Authority
- KR
- South Korea
- Prior art keywords
- pharmaceutical composition
- acid
- tablet
- polyvinyl alcohol
- azelnidipine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006349473 | 2006-12-26 | ||
JPJP-P-2006-349473 | 2006-12-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20090094287A true KR20090094287A (ko) | 2009-09-04 |
Family
ID=39562516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020097012660A KR20090094287A (ko) | 2006-12-26 | 2007-12-25 | 용출성이 개선된 의약 조성물 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5241511B2 (zh) |
KR (1) | KR20090094287A (zh) |
TW (1) | TWI414310B (zh) |
WO (1) | WO2008078727A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101148884B1 (ko) * | 2010-02-01 | 2012-05-29 | 동성제약주식회사 | 용출율이 향상된 올메사탄 메독소밀 함유 고혈압 예방 또는 치료용 조성물 |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5694773B2 (ja) * | 2008-09-30 | 2015-04-01 | テバ製薬株式会社 | 圧縮成型製剤およびその製造方法 |
JP5421945B2 (ja) * | 2010-03-10 | 2014-02-19 | 大日本住友製薬株式会社 | イルベサルタンとアムロジピンまたはその塩を含有する医薬組成物 |
JP6227352B2 (ja) * | 2012-09-27 | 2017-11-08 | 株式会社三和化学研究所 | アナグリプチン又はその塩を含有する固形製剤 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040102502A1 (en) * | 2000-10-25 | 2004-05-27 | Toshifumi Watanabe | Preventing/remedies for portal hypertension |
BRPI0406987A (pt) * | 2003-01-31 | 2006-01-10 | Sankyo Co | Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral |
CN1762354B (zh) * | 2004-10-18 | 2010-07-28 | 上海药明康德新药开发有限公司 | 一种含有钙阻滞剂的稳定药物组合物 |
CN101180052B (zh) * | 2005-05-20 | 2010-11-17 | 第一三共株式会社 | 含有右旋糖的薄膜包衣制剂 |
JP5000491B2 (ja) * | 2005-05-20 | 2012-08-15 | 第一三共株式会社 | フィルムコーティング製剤 |
JP2008543862A (ja) * | 2005-06-15 | 2008-12-04 | エラン ファーマ インターナショナル リミテッド | ナノ粒子アゼルニジピン製剤 |
TWI407978B (zh) * | 2005-06-27 | 2013-09-11 | Sankyo Co | 濕粒狀藥物之製備方法 |
BRPI0612674B8 (pt) * | 2005-06-27 | 2021-05-25 | Daiichi Sankyo Co Ltd | preparação farmacêutica, uso de um antagonista do receptor de angiotensina ii e um bloqueador do canal de cálcio |
JP5110697B2 (ja) * | 2005-06-27 | 2012-12-26 | 第一三共株式会社 | 固形製剤 |
-
2007
- 2007-12-24 TW TW096149681A patent/TWI414310B/zh not_active IP Right Cessation
- 2007-12-25 JP JP2008551105A patent/JP5241511B2/ja active Active
- 2007-12-25 WO PCT/JP2007/074782 patent/WO2008078727A1/ja active Application Filing
- 2007-12-25 KR KR1020097012660A patent/KR20090094287A/ko not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101148884B1 (ko) * | 2010-02-01 | 2012-05-29 | 동성제약주식회사 | 용출율이 향상된 올메사탄 메독소밀 함유 고혈압 예방 또는 치료용 조성물 |
Also Published As
Publication number | Publication date |
---|---|
JP5241511B2 (ja) | 2013-07-17 |
TWI414310B (zh) | 2013-11-11 |
JPWO2008078727A1 (ja) | 2010-04-30 |
TW200833359A (en) | 2008-08-16 |
WO2008078727A1 (ja) | 2008-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007297333B2 (en) | Solid dosage form of olmesartan medoxomil and amlodipine | |
JP5554699B2 (ja) | オルメサルタンメドキソミルを含む製剤の溶出性の改善 | |
JP5351490B2 (ja) | ニフェジピン含有有核錠剤およびその製法 | |
CA2801020A1 (en) | A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide | |
CA2644179C (en) | Novel pharmaceutical composition comprising a disintegration matrix | |
US20120107397A1 (en) | Pharmaceutical compositions of valsartan | |
KR20090094288A (ko) | 고형 제제 | |
KR20090094287A (ko) | 용출성이 개선된 의약 조성물 | |
JP2015003915A (ja) | カルシウム拮抗薬/アンジオテンシンii受容体拮抗薬含有医薬製剤の製造方法 | |
KR20090094285A (ko) | 용출성 개선 방법 | |
CN109481437B (zh) | 一种氯沙坦钾药物制剂 | |
KR20140043517A (ko) | 안정성이 개선된 칸데사르탄 실렉세틸을 함유하는 약제학적 조성물 및 이의 제조방법 | |
JP5824222B2 (ja) | 固形製剤の製造方法 | |
KR101750689B1 (ko) | 약제학적 복합제제 | |
JPWO2008078728A1 (ja) | アスコルビン酸含有医薬組成物 | |
KR20220077092A (ko) | 1-(3-시아노-1-아이소프로필-인돌-5-일)피라졸-4-카르복실산을 포함하는 경구용 제제, 및 그의 제조방법 | |
WO2013050339A1 (en) | Pharmaceutical compositions of antihypertensives | |
GB2471970A (en) | Composition comprising olmesartan medoxomil, amlodipine and hydrochlorothiazide | |
EP2521540A2 (en) | Solid oral dosage form containing olmesartan medoxomil |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |